Status:
UNKNOWN
Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue Imaging
Lead Sponsor:
Fifth Affiliated Hospital, Sun Yat-Sen University
Conditions:
Nasopharyngeal Carcinoma
Eligibility:
All Genders
18-80 years
Brief Summary
Nasopharyngeal cancer is common in China, Southeast Asia, and North Africa, and is usually associated with Epstein-Barr virus (EBV) infection. Using EBV specific antibodies or EBV DNA screening can in...
Detailed Description
Nasopharyngeal cancer is common in China, Southeast Asia, and North Africa, and is generally associated with Epstein-Barr virus (EBV) infection. Using EBV specific antibodies or EBV DNA screening can ...
Eligibility Criteria
Inclusion
- Cancer patients confirmed by histology/cytology
- Patients with nasopharyngeal carcinoma in the training group are initially diagnosed
- Subjects voluntarily participate in the study
Exclusion
- Subjects taking medication or diet may affect their tongue image (such as aluminum magnesium carbonate, traditional Chinese medicine rhubarb, etc.)
- The researchers determined that the subjects had other factors that could force them to terminate the study.
Key Trial Info
Start Date :
November 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT06129201
Start Date
November 15 2023
End Date
December 1 2025
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Fifth Affiliated Hospital of Sun Yat sen University
Zhuhai, China